Barr Laboratories, Inc.

Developer, manufacturer, and marketer of high quality, generic and proprietary pharmaceuticals.
Barr manufactures and distributes generic prescription drug products in various oral, solid dosage forms and strengths. Today, Barr manufactures and markets approximately 74 generic pharmaceutical products, representing various dosage forms and strengths of more than 31 chemical entities.
The Company’s generic business is focused in six primary therapeutic categories – cancer agents; treatments for heart disease; hormone replacement therapies; anti-infectives and antibiotics; psychotherapeutic treatments for such disorders as anxiety and depression; and pain management.

Activity:

- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- Cancer
- Cardiovascular
- Infectious Diseases
- Mental Health
- Neurology
- Pain
- Reproductive Health

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: